Systemic autoimmune diseases: Appropriate serological diagnostics;Systemische auto-immuunziekten: Passende serologische diagnostiek

Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde

Volumn 31, Issue 4, 2006, Pages 257-268

  Hooijkaas, H ^a   Smeenk, R ^b   Gmelig Meyling, F ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Sanquin Diagnostiek   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

ANA; Anti CCP; Antinuclear antibodies; Autoantibodies; ENA; Systemic autoimmune diseases

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY;

ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASE; DERMATOMYOSITIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; MIXED CONNECTIVE TISSUE DISEASE; POLYMYOSITIS; REVIEW; RHEUMATOID ARTHRITIS; SEROLOGY; SJOEGREN SYNDROME; SYNDROME CREST; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

EID: 37049027358     PISSN: 15708306     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Tan EM. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-152.
2. Schellekens GA, Visser H, Jong BAWd, Hoogen FHJ van den, Hazes JMW, Breedveld FC, Venrooij WJ van. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155-163.
3. Limburg PJ en Kallenberg CGM. ANCA en vasculitis, en complexe relatie. Ned Tijdschr Klin Chem Labgeneesk 2006; 31: 289-295.
4. Smeenk RJT. Antinuclear antibodies: cause of disease or caused by disease? Rheumatology 2000; 39: 581-584.
5. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 2000; 124: 71-78.
6. Egner W. The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 2000; 53: 424-432.
7. Dorner TA, Egerer KB, Feist, EB, Burmester GR. Rheumatoid factor revisited. Curr Opin Rheumatol 2004; 16: 246-253.
8. Rantapää-Dahlqvist, S. Diagnostic and prognostic significance of autoantibodies in early rheumatoid arthritis. Scand J Rheumatol 2005; 34: 83-96.
9. Nienhuis RL, Mandema E. A new serum factor in patients with rheumatoid arthritis: the antiperinuclear factor. Ann Rheum Dis. 1964; 23: 302-305.
10. Vallbracht I, Helmke K. Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Autoimmun Rev 2005; 4: 389-394.
11. Mimori, T. Clinical significance of the anti-CCP antibodies in rheumatoid arthritis. Internal Med 2005; 44: 1122-1126.
12. Iwamoto T, Ikari K, Nakamura T, Kuwahara M, Toyama Y, Tomatsu T, Momohara S, Kamatani N. Association between PADI4 and rheumatoid arthritis: a meta-analysis. Rheumatology 2006; 45: 804-807.
13. Hooijkaas, H. Hoe is de correlatie tussen RF-test en anti-CCP test? Wat betekent het als de RF positief is en de anti-CCP negatief? Reumatologen Vademecum 2006; 9.
14. Bruggen MC van, Walgreen B, Rijke TP, Tamboer W, Kramers K, Smeenk RJ, Monestier M, Fournie GJ, Berden JH. Antigen specificity of antinuclear antibodies complexed to nucleosomes determines glomerular basement membrane binding in vivo. Eur J Immunol 1997; 27: 1564-1569.
15. Buyon JP, Kim MY, Copel JA, Friedman DM. Anti-Ro/SSA antibodies and congenital heart block: necessary but not sufficient. Arthritis Rheum 2001; 44: 1723-1727.
16. Salomonsson S, Sonesson SE, Ottosson L, Muhallab S, Olsson T, Sunnerhagen M, Kuchroo VK, Thoren P, Herlenius E, Wahren-Herlenius M. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 2005; 201: 11-17.
17. Waldman M, Madaio MP. Pathogenic autoantibodies in lupus nephritis. Lupus 2005; 14: 19-24.
18. Rijkers GT, Prakken BJ. Verstoorde immuunregulatie bij auto-immuniteit. Ned Tijdschr Klin Chem Labgeneesk 2006; 31: 248-256.
19. Walport MJ, Davies KA, Botto M. C1q and systemic lupus erythematosus. Immunobiology 1998; 199: 265-285.
20. Haugbro K, Nossent JC, Winkler T, Figenschau Y, Rekvig OP. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity. Ann Rheum Dis 2004; 63: 386-394.
21. Arbuckle MR, James JA, Kohlhase KF, Rubertone MV, Dennis GJ, Harley JB. Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand J Immunol 2001; 54: 211-219.
22. Swaak AJG, Smeenk R. Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non Systemic Lupus Erythematosus (SLE) patients with anti-dsDNA antibody (anti-dsDNA). Ann Rheum Dis 1985; 44: 245-251.
23. Bootsma H, Spronk P, Derksen R, de Boer G, Wolters-Dicke H, Hermans J, Limburg P, Gmelig-Meyling F, Kater L, Kallenberg C. Prevention of relapses in systemic lupus erythematosus. Lancet 1995; 345: 1595-1599.
24. Feltkamp TEW, Kirkwood TBL, Maini RN, Aarden LA. The first international standard for antibodies to dsDNA. Ann Rheum Dis 1988; 47: 740-746.
25. Monestier M. Autoantibodies to nucleosomes and histone-DNA complexes. Methods 1997; 11: 36-43.
26. Burlingame RW, Cervera R. Anti-chromatin (anti-nucleosome) autoantibodies. Autoimmun Rev 2002; 1: 321-328.
27. Burlingame RW, Rubin RL. Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin. J Clin Invest 1991; 88: 680-690.
28. Fox RI. Sjögren's syndrome. Lancet 2005; 366: 321-331.
29. Merwe JP van de (red.). Het syndroom van Sjögren: meer dan een droge mond en droge ogen. Wychen: Landelijke Werkgroep Sjögren patiënten, 1999.
30. Bakker-Jonges LE, Hooijkaas H. Recente ontwikkelingen in auto-antistofbepalingen bij de diagnostiek van auto-immuunziekten. In: Hooijkaas H, Dongen JJM van (red.). Nieuwe ontwikkelingen in de medische immunologie. Rotterdam, Afdeling Immunologie. 2006; 43-54.
31. Brouwer R, Hengstman GJ, Vree Egberts W, Ehrfeld H, Bozic B, Ghirardello A, Grondal G, Hietarinta M, Isenberg D, Kalden JR, Lundberg I, Moutsopoulos H, Roux-Lombard P, Vencovsky J, Wikman A, Seelig HP, van Engelen BG, van Venrooij WJ. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001; 60: 116-123.
32. Hooijkaas H. In: Merwe JP van de (red.). Het syndroom van Sjögren: meer dan een droge mond en droge ogen. Wychen. Landelijke Werkgroep Sjögren patiënten. 1999; 43-49.
33. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52: 148-159.
34. Venables PJ. Mixed connective tissue disease. Lupus 2006; 15: 132-137.
35. Black CM. The aetiopathogenesis of systemic sclerosis: thick skin-thin hypotheses. The Parkes Weber Lecture 1994. J R Coll Physicians Lond 1995; 29: 119-130.
36. Wollheim FA. Classification of systemic sclerosis. Visions and reality. Rheumatology 2005; 44: 1212-1216.
37. Reveille JD, Solomon DH. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. Arthritis Rheum 2003; 49: 399-412.
38. Charles C, Clements P, Furst DE. Systemic sclerosis: hypothesis-driven treatment strategies. Lancet 2006; 367: 1683-1691.
39. Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, Fraticelli P, Sambo P, Funaro A, Kazlauskas A, Avvedimento EV, Gabrielli A. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 2006; 354: 2667-2676.
40. Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y. Clinical and serological heterogeneity in patients with anticentromere antibodies. J Rheumatol 2005; 32: 1488-1494.
41. Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005; 35: 35-42.
42. Lyons R, Narain S, Nichols C, Satoh M, Reeves WH. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease. Ann N Y Acad Sci 2005; 1050: 217-228.
43. Plotz PH, Rider LG, Targoff IN, Raben N, O'Hanlon TP, Miller FW. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 1995; 122: 715-724.
44. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003; 362: 971-982.
45. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senecal JL. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 2005; 84: 231-249.
46. Sarkar K, Miller FW. Autoantibodies as predictive and diagnostic markers of idiopathic inflammatory myopathies. Autoimmunity 2004; 37: 291-294.
47. Hengstman GJ, Brouwer R, Egberts WT, Seelig HP, Jongen PJ, Venrooij WJ van, Engelen BG van. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. J Neurol 2002; 249: 69-75.
48. Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C, Rondinone R, Sarzi-Puttini P, Todesco S, Doria A. Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity 2006; 39: 217-221.
49. Zampieri S, Ghirardello A, Iaccarino L, Tarricone E, Gambari PF, Doria A. Anti-Jo-1 antibodies. Autoimmunity 2005; 38: 73-78.
50. Selva-O'Callaghan A, Labrador-Horrillo M, Munoz-Gall X, Martinez-Gomez X, Majo-Masferrer J, Solans-Laque R, Simeon-Aznar CP, Morell-Brotard F, Vilardell-Tarres M. Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients. Lupus 2005; 14: 534-542.
51. Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Bendo R, Gambari PF, Doria A. Anti-Mi-2 antibodies. Autoimmunity 2005; 38: 79-83.
52. Vandergheynst F, Ocmant A, Sordet C, Humbel RL, Goetz J, Roufosse F, Cogan E, Sibilia J. Anti-pm/scl antibodies in connective tissue disease: Clinical and biological assessment of 14 patients. Clin Exp Rheumatol 2006; 24: 129-133.
53. Erkan D, Lockshin MD. Antiphospholipid syndrome. Curr Opin Rheumatol 2006; 18: 242-248.
54. Koike T, Matsuura E. What is the 'true' antigen for anticardiolipin antibodies. Lancet 1991; 337: 671-672.
55. Pierangeli SS, Harris EN. Clinical laboratory testing for the antiphospholipid syndrome. Clin Chim Acta 2005; 357: 17-33.
56. rd edition. BMJ Publishing Group Ltd., London 2004, 92-95.